Early screening of lung function by electrical impedance tomography in people with normal spirometry reveals unrecognized pathological features.
Summary
Electrical impedance tomography revealed regional time-constant abnormalities indicative of lung pathology in individuals with normal spirometry. With CT as the reference, EIT-based screening achieved sensitivities of 81.3% (concept phase) and 77.9% (validation phase), highlighting its promise for early detection of subclinical lung dysfunction.
Key Findings
- In people with normal spirometry, EIT detected abnormal regional time constants consistent with unrecognized pathology.
- CT-referenced sensitivity was 81.3% in the concept phase and 77.9% in the validation phase; specificity was 50%.
- The study underscores that spirometry may miss early regional dysfunction measurable by EIT.
Clinical Implications
EIT could complement spirometry to flag high-risk individuals for confirmatory imaging and early intervention, potentially preventing progression to overt disease.
Why It Matters
Introduces a noninvasive, bedside-capable imaging biomarker to detect early regional lung dysfunction before spirometric changes, potentially changing screening paradigms.
Limitations
- Specificity was modest (50%), and CT confirmation was performed in subsets flagged by EIT or smoking history, introducing selection bias.
- Cross-sectional design without longitudinal clinical outcomes.
Future Directions
Longitudinal studies linking EIT abnormalities to clinical outcomes, optimization of thresholds, and integration into risk-based screening pathways.
Study Information
- Study Type
- Cohort (diagnostic)
- Research Domain
- Diagnosis
- Evidence Level
- II - Prospective diagnostic evaluation with validation cohort and CT reference.
- Study Design
- OTHER